PerkinElmer reports further growth in first quarter of 2014

PerkinElmer has announced its financial results for the first quarter of 2014, during which it achieved a revenue total of $531.9 million (316.29 million pounds).

This represented a reported and organic year-on-year increase of five percent, with both its human and environmental health divisions seeing improved performances. The company was also able to increase its income and earnings figures compared to Q1 2013.

Meanwhile, operating cash flow from continuing operations was $67.9 million, compared to $11.1 million in the comparable period last year, owing to lower pension funding and reduced royalty payments.

For the full year 2014, PerkinElmer now forecasts an earnings per share total from continuing operations in the range of $1.91 to $1.95, based on its solid start to the business year.

Robert Friel, chairman and chief executive officer of PerkinElmer, said: "I am encouraged by our opportunities to accelerate revenue growth this year as we innovate across our core capabilities to better serve our customers."

Earlier this month, the company attended the Analytica 2014 industry conference in Munich, where it unveiled its latest technology offerings for environmental and life sciences laboratory professionals.